Physician profile
Michael A Bohl
NPI 1073952974
$120,203.76
in general payments reported to CMS, 2019-2025
26 companies · $50K in 2025
The $50K reported for 2025 was more than what 95% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,397 · 2020: $13K · 2021: $8,610 · 2022: $4,075 · 2023: $18K · 2024: $18K · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $73K · Travel and Lodging: $5,514 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,374 · Food and Beverage: $3,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $72,517.50 |
| Travel and Lodging | $5,514.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,374.05 |
| Food and Beverage | $3,940.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $77,835.81 | 2019-2025 | Velys, Conduit |
| Stryker Corporation | $8,262.54 | 2019-2025 | Everest Spinal System, Sonopet Iq, Core |
| Mirus, LLC | $8,012.06 | 2020-2022 | |
| Depuy Synthes Products, INC. | $5,155.00 | 2020-2024 | |
| Bioventus LLC | $4,396.00 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Nuvasive, INC. | $3,743.51 | 2019-2023 | Reline, Tlif |
| Globus Medical, INC. | $3,511.99 | 2019-2025 | Excelsiusgps Robotic Navigation System, Excelsius Gps, Magec Spinal Bracing and Distraction System |
| Depuy Synthes Sales INC. | $3,273.53 | 2019-2025 | Expedium, Trialtis, Symphony |
| Biocomposites INC | $1,500.00 | 2023 | Stimulan |
| Spine Wave, INC. | $1,426.81 | 2020-2022 | |
| Medicrea USA, Corp. | $1,214.97 | 2019 | |
| Carlsmed, INC. | $397.63 | 2022-2024 | Aprevo |
| Medtronic, INC. | $276.82 | 2021-2025 | Mazor X System, Cd Horizon Spinal System, Navlock |
| Alphatec Spine, INC | $183.67 | 2022-2025 | Other - Miscellaneous |
| Ethicon US, LLC | $182.51 | 2023-2024 | Dermabond Prineo, Ethicon |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $174.05 | 2023 | |
| Icotec Medical INC. | $140.00 | 2024 | Vader Pedicle System |
| Ulrich Medical USA, INC. | $110.18 | 2023 | |
| Arbor Pharmaceuticals, INC. | $100.00 | 2022 | |
| Providence Medical Technology, INC. | $90.61 | 2023-2025 | |
| Medtronic USA, INC. | $59.72 | 2020 | |
| Djo, LLC | $56.76 | 2021-2025 | Cmf |
| Spineology INC. | $34.24 | 2023 | Optimesh Expandable Interbody Fusion System |
| Intrinsic Therapeutics | $26.72 | 2023 | Barricaid Acd (Annular Closure Device) |
| Aesculap, INC. | $23.64 | 2022 | |
| Sanara Medtech INC. | $14.99 | 2024 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bohl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.